Cherry Creek Investment Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $881K | Buy |
7,943
+693
| +10% | +$76.8K | 0.41% | 43 |
|
|
2025
Q1 | $812K | Buy |
7,250
+1,950
| +37% | +$218K | 0.42% | 41 |
|
|
2024
Q4 | $490K | Buy |
5,300
+40
| +0.8% | +$3.7K | 0.24% | 58 |
|
|
2024
Q3 | $441K | Buy |
5,260
+317
| +6% | +$26.6K | 0.23% | 60 |
|
|
2024
Q2 | $339K | Sell |
4,943
-1,761
| -26% | -$121K | 0.18% | 79 |
|
|
2024
Q1 | $491K | Sell |
6,704
-79
| -1% | -$5.79K | 0.27% | 61 |
|
|
2023
Q4 | $549K | Buy |
6,783
+54
| +0.8% | +$4.37K | 0.34% | 53 |
|
|
2023
Q3 | $504K | Buy |
6,729
+58
| +0.9% | +$4.35K | 0.34% | 51 |
|
|
2023
Q2 | $514K | Buy |
6,671
+231
| +4% | +$17.8K | 0.35% | 50 |
|
|
2023
Q1 | $534K | Sell |
6,440
-266
| -4% | -$22.1K | 0.39% | 50 |
|
|
2022
Q4 | $576K | Sell |
6,706
-43
| -0.6% | -$3.69K | 0.45% | 49 |
|
|
2022
Q3 | $416K | Buy |
6,749
+74
| +1% | +$4.56K | 0.34% | 52 |
|
|
2022
Q2 | $413K | Buy |
6,675
+217
| +3% | +$13.4K | 0.33% | 56 |
|
|
2022
Q1 | $384K | Buy |
6,458
+729
| +13% | +$43.3K | 0.25% | 69 |
|
|
2021
Q4 | $416K | Buy |
5,729
+1,027
| +22% | +$74.6K | 0.26% | 63 |
|
|
2021
Q3 | $328K | Buy |
4,702
+132
| +3% | +$9.21K | 0.22% | 76 |
|
|
2021
Q2 | $315K | Buy |
+4,570
| New | +$315K | 0.21% | 79 |
|